Published in Nuklearmedizin on August 01, 1976
Ethical guidelines for investigations of experimental pain in conscious animals. Pain (1983) 17.70
Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000. Leukemia (2009) 2.78
The Concise Guide to PHARMACOLOGY 2013/14: overview. Br J Pharmacol (2013) 2.48
Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS) Blood (1997) 2.40
Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin-Frankfurt-Münster. Leukemia (2000) 2.21
Nervous outflow from the cat's foot during noxious radiant heat stimulation. Brain Res (1974) 2.18
Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86. Blood (1994) 2.11
Facilitation at the frog neuromuscular junction during and after repetitive stimulation. Pflugers Arch Gesamte Physiol Menschen Tiere (1966) 2.09
Serum S-100B protein in severe head injury. Neurosurgery (1999) 2.08
Single unit responses and the total afferent outflow from the cat's foot pad upon mechanical stimulation. Exp Brain Res (1968) 2.04
Reduction of wound infections in laparoscopic-assisted colorectal resections by plastic wound ring drapes (REDWIL)?--A randomized controlled trial. Langenbecks Arch Surg (2012) 2.01
Myelodysplasia and acute myelogenous leukemia in Down's syndrome. A report of 40 children of the AML-BFM Study Group. Leukemia (1996) 1.96
Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group report. Blood (2000) 1.93
[Ethic charter of the German Society for the Study of Pain (DGSS)]. Schmerz (2008) 1.83
Idarubicin improves blast cell clearance during induction therapy in children with AML: results of study AML-BFM 93. AML-BFM Study Group. Leukemia (2001) 1.67
Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials. Leukemia (2005) 1.60
The favorable effect of activating NOTCH1 receptor mutations on long-term outcome in T-ALL patients treated on the ALL-BFM 2000 protocol can be separated from FBXW7 loss of function. Leukemia (2010) 1.56
AML patients with Down syndrome have a high cure rate with AML-BFM therapy with reduced dose intensity. Leukemia (2005) 1.51
Mutations in KIT and RAS are frequent events in pediatric core-binding factor acute myeloid leukemia. Leukemia (2005) 1.50
Colocalization and coprecipitation of ankyrin and Na+,K+-ATPase in kidney epithelial cells. Eur J Cell Biol (1988) 1.50
European survey on efficacy and safety of duty-cycled radiofrequency ablation for atrial fibrillation. Europace (2012) 1.45
Down's syndrome in childhood acute lymphoblastic leukemia: clinical characteristics and treatment outcome in four consecutive BFM trials. Berlin-Frankfurt-Münster Group. Leukemia (1998) 1.44
[Back pain: guidelines for drug therapy. Utilize the therapeutic spectrum]. MMW Fortschr Med (2000) 1.40
Segmental and supraspinal actions on dorsal horn neurons responding to noxious and non-noxious skin stimuli. Pain (1975) 1.39
Low efficacy of methotrexate in childhood acute myeloid leukemia (AML): single-agent therapeutic window study in relapsed AML. Pediatr Blood Cancer (2006) 1.39
[The need for autonomy in the process of care-conceptual framework and research perspectives]. Z Gerontol Geriatr (2006) 1.38
[Positive tests for serum anti-endomysium antibodies (AEA) and anti-jejunal antibodies (JAB) and histopathological diagnosis of celiac disease in children]. Vnitr Lek (2008) 1.38
Calendar life span versus budding life span of Saccharomyces cerevisiae. Mech Ageing Dev (1980) 1.36
Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia: data from the trials ALL-BFM 86, 90, and 95. Klin Padiatr (2005) 1.32
Two specific feedback pathways to the central afferent terminals of phasic and tonic mechanoreceptors. Exp Brain Res (1968) 1.31
Chronic pain/dysaesthesiae in spinal cord injury patients: results of a multicentre study. Spinal Cord (1997) 1.29
Multidisciplinary rehabilitation programmes following joint replacement at the hip and knee in chronic arthropathy. Cochrane Database Syst Rev (2008) 1.27
Distinct regulation of IgE, IgG4 and IgA by T regulatory cells and toll-like receptors. Allergy (2008) 1.27
Cooperative study group for childhood acute lymphoblastic leukaemia (COALL): long-term results of trials 82,85,89,92 and 97. Leukemia (2009) 1.25
Consequent and intensified relapse therapy improved survival in pediatric AML: results of relapse treatment in 379 patients of three consecutive AML-BFM trials. Leukemia (2010) 1.20
Favorable prognostic impact of NPM1 gene mutations in childhood acute myeloid leukemia, with emphasis on cytogenetically normal AML. Leukemia (2008) 1.18
A microsomal protein is involved in ATP-dependent transport of presecretory proteins into mammalian microsomes. EMBO J (1991) 1.18
Extracorporeal pumpless interventional lung assist in clinical practice: determinants of efficacy. Eur Respir J (2008) 1.17
Determinants of the spontaneous ectopic activity in repetitive monomorphic idiopathic ventricular tachycardia. J Am Coll Cardiol (1986) 1.17
NUP98/JARID1A is a novel recurrent abnormality in pediatric acute megakaryoblastic leukemia with a distinct HOX gene expression pattern. Leukemia (2013) 1.16
Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemia. Leukemia (2011) 1.15
Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: results of Study Acute Myeloid Leukemia-Berlin-Frankfurt-Münster 93. J Clin Oncol (2001) 1.15
Acute megakaryoblastic leukemia in children and adolescents, excluding Down's syndrome: improved outcome with intensified induction treatment. Leukemia (2005) 1.14
Ethical considerations in relation to pain in animal experimentation. Acta Physiol Scand Suppl (1986) 1.14
Contributions of the inside and outside leg to maintenance of curvilinear motion on a natural turf surface. Gait Posture (2006) 1.13
Platelet APP, ADAM 10 and BACE alterations in the early stages of Alzheimer disease. Neurology (2004) 1.12
Difference in configuration of ruptured and unruptured intracranial aneurysms determined by biplanar digital subtraction angiography. Acta Neurochir (Wien) (2003) 1.12
New limits on the drift of fundamental constants from laboratory measurements. Phys Rev Lett (2004) 1.11
Incidence of tumor lysis syndrome in children with advanced stage Burkitt's lymphoma/leukemia before and after introduction of prophylactic use of urate oxidase. Ann Hematol (2003) 1.11
Altered expression of Bcl-2, Bcl-X, Bax, and c-Fos colocalizes with DNA fragmentation and ischemic cell damage following middle cerebral artery occlusion in rats. Brain Res Mol Brain Res (1996) 1.10
Intervertebral disc calcification in childhood--a case report and review of the literature. Acta Neurochir (Wien) (2001) 1.09
Development of a boxing dynamometer and its punch force discrimination efficacy. J Sports Sci (2000) 1.09
Management and results of complications after anterior resection with colonic pouch reconstruction for rectal cancer. Colorectal Dis (2011) 1.09
Endothelin concentrations in patients with aneurysmal subarachnoid hemorrhage. Correlation with cerebral vasospasm, delayed ischemic neurological deficits, and volume of hematoma. J Neurosurg (1995) 1.08
Dorsal root potentials after C-fiber stimulation. Science (1968) 1.08
Prevalence and prognostic value of IDH1 and IDH2 mutations in childhood AML: a study of the AML-BFM and DCOG study groups. Leukemia (2011) 1.07
Isn't it time to teach nutrition to medical students? Am J Clin Nutr (1993) 1.07
EVI1 overexpression in distinct subtypes of pediatric acute myeloid leukemia. Leukemia (2010) 1.07
Outcome in children with Down's syndrome and acute lymphoblastic leukemia: role of IKZF1 deletions and CRLF2 aberrations. Leukemia (2012) 1.06
Presynaptic depolarization of cutaneous mechanoreceptor afferents after mechanical skin stimulation. Exp Brain Res (1967) 1.05
Relationship between habitual physical activity and physical fitness. Am J Clin Nutr (1971) 1.05
[Effect of diazepam on presynaptic inhibition and other spinal reflexes]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1967) 1.04
Peculiarities of the regulation of fermentation and respiration in the crabtree-negative, xylose-fermenting yeast Pichia stipitis. Appl Biochem Biotechnol (1996) 1.04
Analysis of a family of cyclin-dependent kinase inhibitors: p15/MTS2/INK4B, p16/MTS1/INK4A, and p18 genes in acute lymphoblastic leukemia of childhood. Blood (1995) 1.02
Factor XIII deficiency and postoperative hemorrhage after neurosurgical procedures. Surg Neurol (2000) 1.01
Successful treatment strategy for Ki-1 anaplastic large-cell lymphoma of childhood: a prospective analysis of 62 patients enrolled in three consecutive Berlin-Frankfurt-Munster group studies. J Clin Oncol (1994) 1.01
The use of local anaesthetic microinjections to identify central pathways: a quantitative evaluation of the time course and extent of the neuronal block. Exp Brain Res (1987) 1.00
Clivus lymphoma. Acta Neurochir (Wien) (2004) 0.99
Long-term depression of C-fibre-evoked spinal field potentials by stimulation of primary afferent A delta-fibres in the adult rat. Eur J Neurosci (1998) 0.99
Selective activation of C-fibers. Pflugers Arch Gesamte Physiol Menschen Tiere (1968) 0.99
The membrane proteins TRAMp and sec61 alpha p may be involved in post-translational transport of presecretory proteins into mammalian microsomes. FEBS Lett (1994) 0.99
Hsc70, immunoglobulin heavy chain binding protein, and Hsp90 differ in their ability to stimulate transport of precursor proteins into mammalian microsomes. J Biol Chem (1993) 0.98
The metabolic activity of gut microbiota in obese children is increased compared with normal-weight children and exhibits more exhaustive substrate utilization. Nutr Diabetes (2011) 0.98
Expression pattern of candidate cell death effector proteins Bax, Bcl-2, Bcl-X, and c-Jun in sensory and motor neurons following sciatic nerve transection in the rat. Brain Res (1996) 0.97
Allogeneic bone marrow transplantation for chronic myelomonocytic leukemia in childhood: a report from the European Working Group on Myelodysplastic Syndrome in Childhood. J Clin Oncol (1997) 0.96
Loss of heterozygosity on chromosome 6q14-q24 is associated with poor outcome in children and adolescents with T-cell lymphoblastic lymphoma. Leukemia (2006) 0.96
Characteristics of spinal neurones responding to cutaneous myelinated and unmyelinated fibres. J Physiol (1972) 0.95
External nucleus of inferior colliculus: auditory and spinal somatosensory afferents and their interactions. J Neurophysiol (1978) 0.94
Clinical significance of surface antigen expression in children with acute myeloid leukemia: results of study AML-BFM-87. Blood (1995) 0.94
Expression of nitric oxide synthase and colocalisation with Jun, Fos and Krox transcription factors in spinal cord neurons following noxious stimulation of the rat hindpaw. Brain Res Mol Brain Res (1994) 0.94
Response of chronic neuropathic pain syndromes to ketamine: a preliminary study. Pain (1994) 0.94
Long-lasting increase of nitric oxide synthase immunoreactivity, NADPH-diaphorase reaction and c-JUN co-expression in rat dorsal root ganglion neurons following sciatic nerve transection. Neurosci Lett (1993) 0.94
Up-regulation of bax and down-regulation of bcl-2 is associated with kainate-induced apoptosis in mouse brain. Neurosci Lett (1995) 0.94
Differential blocking of myelinated nerve fibres by transient depolarization. Pflugers Arch (1973) 0.93
Dendritic cell deficiencies in pediatric acute lymphoblastic leukemia patients. Leukemia (2006) 0.93
Increase in bax expression in substantia nigra following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment of mice. Neurosci Lett (1996) 0.93
Non-Hodgkin's lymphoma in adolescents: experiences in 378 adolescent NHL patients treated according to pediatric NHL-BFM protocols. Leukemia (2010) 0.93
Pumpless extracorporeal removal of carbon dioxide combined with ventilation using low tidal volume and high positive end-expiratory pressure in a patient with severe acute respiratory distress syndrome. Anaesthesia (2009) 0.92
Favorable outcome in infants with AML after intensive first- and second-line treatment: an AML-BFM study group report. Leukemia (2011) 0.92
Use of minimal disseminated disease and immunity to NPM-ALK antigen to stratify ALK-positive ALCL patients with different prognosis. Leukemia (2012) 0.92
Intermediate dose methotrexate is as effective as high dose methotrexate in preventing isolated testicular relapse in childhood acute lymphoblastic leukemia. J Pediatr Hematol Oncol (1998) 0.92